Gamifant (emapalumab-lzsg) / SOBI  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gamifant (emapalumab-lzsg) / SOBI
NCT05744063: A Post-authorization Study to Describe the Safety and Efficacy of Emapalumab for the Treatment of pHLH in Treatment Experienced Chinese Patients

Active, not recruiting
4
13
RoW
Emapalumab-Lzsg 5 MG/ML [Gamifant], Gamifant
Swedish Orphan Biovitrum
Primary Hemophagocytic Lymphohistiocytosis
07/25
07/25

Download Options